Skip to content

Effect of Kareeradi Kwath in the management of Shweta pradara

Evaluate the efficacy of Kareeradi Kwath versus Panchvalkal Kwath (as Yoni Prakshalan) in the management of Shwetapradar (leucorrhoea): A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048597
Enrollment
60
Registered
2022-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Pooja Basanl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients from Age 18 year to 55 year in reproductive period of life will be included in this study irrespective of marital status Married/unmarried femaleâ??s patients will be taken for this study Female patients having signs and symptoms of Shweta Pradaraa will be included

Exclusion criteria

Exclusion criteria: Female patients having signs and symptoms of abnormal Vaginal Bleeding such as menorrhagia metrorrhagia Female patients having pregnancy will be excluded from this study Female patients having Hormonal misbalance diabetes HTN Those patients who are having carcinoma or other severe systemic illness

Design outcomes

Primary

MeasureTime frame
evaluate the efficacy of Kareeradi Kwatha (as Yoni Prakshalan) in Shweta Pradara (leucorrhoea)Timepoint: 16 days

Secondary

MeasureTime frame
evaluate the efficacy of Panchvalkal Kwath (as Yoni Prakshalan) in Shweta Pradara (leucorrhoea) Timepoint: 2 weeks 2 days

Countries

India

Contacts

Public ContactDr Pooja Basnal

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha

preeti.borkar@dmimsu.edu.in8446127058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026